<DOC>
	<DOC>NCT02622243</DOC>
	<brief_summary>The study will assess the duration of protection of single doses of 2 different long acting muscarinic antagonists against methacholine induced bronchoconstriction.</brief_summary>
	<brief_title>Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge</brief_title>
	<detailed_description />
	<mesh_term>Glycopyrrolate</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<mesh_term>Methacholine Chloride</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>male or female asthmatics &gt; 19 years of age baseline methacholine PC20 less than or equal to 4mg/ml baseline lung function &gt;65% predicted nonsmoker and less than 10 pack year smoking history use of anticholinergic within 30 days of Visit 1 poorly controlled asthma pregnant or nursing respiratory illness within 4 weeks of Visit 1 exposure to an agent that triggered asthma worsening (e.g. allergen) within 4 weeks of Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>